Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, December 2001, p. 3387-3392, Vol. 45, No. 12
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.12.3387-3392.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Intrinsic Resistance of Mycobacterium
smegmatis to Fluoroquinolones May Be Influenced by New
Pentapeptide Protein MfpA
Clemente
Montero,
Guaniri
Mateu,
Rosalva
Rodriguez, and
Howard
Takiff*
Laboratorio de Genética Molecular,
Centro de Microbiología y Biología Celular, Instituto
de Investigaciones Cientificas (IVIC), Caracas 1020A, Venezuela
Received 18 April 2001/Returned for modification 27 June
2001/Accepted 14 August 2001
The fluoroquinolones (FQ) are used in the treatment of
Mycobacterium tuberculosis, but the
development of resistance could limit their effectiveness. FQ
resistance (FQR) is a multistep process involving
alterations in the type II topoisomerases and perhaps in the regulation
of efflux pumps, but several of the steps remain unidentified.
Recombinant plasmid pGADIV was selected from a genomic library of
wild-type (WT), FQ-sensitive M. smegmatis
by its ability to confer low-level resistance to sparfloxacin (SPX). In
WT M. smegmatis, pGADIV increased the MICs of ciprofloxacin (CIP) by fourfold and of SPX by eightfold, and in
M. bovis BCG it increased the MICs of
both CIP and SPX by fourfold. It had no effect on the accumulation of
14C-labeled CIP or SPX. The open reading frame responsible
for the increase in FQR, mfpA, encodes a
putative protein belonging to the family of pentapeptides, in which
almost every fifth amino acid is either leucine or phenylalanine. Very
similar proteins are also present in M.
tuberculosis and M. avium.
The MICs of CIP and SPX were lower for an M.
smegmatis mutant strain lacking an intact
mfpA gene than for the WT strain, suggesting that, by
some unknown mechanism, the gene product plays a role in determining
the innate level of FQR in M.
smegmatis.
*
Corresponding author. Mailing address: Laboratorio de
Genética Molecular, Centro de Microbiología y
Biología Celular, Instituto de Investigaciones Cientificas
(IVIC), Apdo. 21827, Caracas 1020A, Venezuela. Phone: 58 212 504 1439. Fax: 58 212 504 1499. E-mail: htakiff{at}ivic.ve.

Present address: Department of Chemical Engineering, North Carolina
State University, Raleigh, N.C.
Antimicrobial Agents and Chemotherapy, December 2001, p. 3387-3392, Vol. 45, No. 12
0066-4804/01/$04.00+0 DOI: 10.1128/AAC.45.12.3387-3392.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Strahilevitz, J., Jacoby, G. A., Hooper, D. C., Robicsek, A.
(2009). Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat. Clin. Microbiol. Rev.
22: 664-689
[Abstract]
[Full Text]
-
Merens, A., Matrat, S., Aubry, A., Lascols, C., Jarlier, V., Soussy, C.-J., Cavallo, J.-D., Cambau, E.
(2009). The Pentapeptide Repeat Proteins MfpAMt and QnrB4 Exhibit Opposite Effects on DNA Gyrase Catalytic Reactions and on the Ternary Gyrase-DNA-Quinolone Complex. J. Bacteriol.
191: 1587-1594
[Abstract]
[Full Text]
-
Rodriguez-Martinez, J. M., Velasco, C., Briales, A., Garcia, I., Conejo, M. C., Pascual, A.
(2008). Qnr-like pentapeptide repeat proteins in Gram-positive bacteria. J Antimicrob Chemother
61: 1240-1243
[Abstract]
[Full Text]
-
Cesaro, A., Bettoni, R. R. D., Lascols, C., Merens, A., Soussy, C. J., Cambau, E.
(2008). Low selection of topoisomerase mutants from strains of Escherichia coli harbouring plasmid-borne qnr genes. J Antimicrob Chemother
61: 1007-1015
[Abstract]
[Full Text]
-
Hashimi, S. M., Wall, M. K., Smith, A. B., Maxwell, A., Birch, R. G.
(2007). The Phytotoxin Albicidin is a Novel Inhibitor of DNA Gyrase. Antimicrob. Agents Chemother.
51: 181-187
[Abstract]
[Full Text]
-
Sengupta, S., Shah, M., Nagaraja, V.
(2006). Glutamate racemase from Mycobacterium tuberculosis inhibits DNA gyrase by affecting its DNA-binding. Nucleic Acids Res
34: 5567-5576
[Abstract]
[Full Text]
-
Nordmann, P., Poirel, L.
(2005). Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother
56: 463-469
[Abstract]
[Full Text]
-
Hegde, S. S., Vetting, M. W., Roderick, S. L., Mitchenall, L. A., Maxwell, A., Takiff, H. E., Blanchard, J. S.
(2005). A Fluoroquinolone Resistance Protein from Mycobacterium tuberculosis That Mimics DNA. Science
308: 1480-1483
[Abstract]
[Full Text]
-
Mammeri, H., Van De Loo, M., Poirel, L., Martinez-Martinez, L., Nordmann, P.
(2005). Emergence of Plasmid-Mediated Quinolone Resistance in Escherichia coli in Europe. Antimicrob. Agents Chemother.
49: 71-76
[Abstract]
[Full Text]
-
Tran, J. H., Jacoby, G. A., Hooper, D. C.
(2005). Interaction of the Plasmid-Encoded Quinolone Resistance Protein Qnr with Escherichia coli DNA Gyrase. Antimicrob. Agents Chemother.
49: 118-125
[Abstract]
[Full Text]
-
Wang, M., Sahm, D. F., Jacoby, G. A., Hooper, D. C.
(2004). Emerging Plasmid-Mediated Quinolone Resistance Associated with the qnr Gene in Klebsiella pneumoniae Clinical Isolates in the United States. Antimicrob. Agents Chemother.
48: 1295-1299
[Abstract]
[Full Text]
-
Jacoby, G. A., Chow, N., Waites, K. B.
(2003). Prevalence of Plasmid-Mediated Quinolone Resistance. Antimicrob. Agents Chemother.
47: 559-562
[Abstract]
[Full Text]
-
Tran, J. H., Jacoby, G. A.
(2002). Mechanism of plasmid-mediated quinolone resistance. Proc. Natl. Acad. Sci. USA
99: 5638-5642
[Abstract]
[Full Text]
-
Tran, J. H., Jacoby, G. A.
(2002). Mechanism of plasmid-mediated quinolone resistance. Proc. Natl. Acad. Sci. USA
99: 5638-5642
[Abstract]
[Full Text]